| 摘要: |
| ［摘要］ 目的 观察肺炎支原体感染后咳嗽应用布地奈德雾化吸入治疗的临床疗效。方法 将收治的肺炎支原体感染后咳嗽患者120例，按数字奇偶法半随机分为对照组和治疗组各60例。对照组给予常规肺炎感染后咳嗽治疗，治疗组给予布地奈德雾化吸入治疗，均持续治疗14 d。观察两组患者疗效及治疗前后咳嗽症状评分变化情况。结果 两组治疗前咳嗽症状评分比较差异无统计学意义（P>0.05），治疗后治疗组评分低于对照组（P<0.05）。治疗组临床疗效明显优于对照组（P<0.05）。治疗组住院时间及咳嗽消失时间短于对照组（P<0.05）。结论 肺炎支原体感染后咳嗽患者应用布地奈德雾化吸入治疗，能有效改善患者咳嗽症状，缩短住院时间，减轻患者痛苦，疗效显著。 |
| 关键词: 肺炎感染 咳嗽 布地奈德 疗效 |
| DOI：10.3969/j.issn.1674-3806.2016.07.14 |
| 分类号:R 563 |
| 基金项目: |
|
| Observation on efficacy of budesonide aerosol inhalation applied in cough following mycoplasma pneumonia |
|
LIANG Xu-man
|
|
Department of Respiratory Medicine, Yangjiang TCM Hospital, Guangdong 529500, China
|
| Abstract: |
| ［Abstract］ Objective To explore the clinical effects of budesonide aerosol inhalation therapy on the cough following mycoplasma pneumonia infection.Methods One hundred and twenty patients with cough following mycoplasma pneumonia infection were randomly divided into two groups, with 60 cases in each group. The control group recieved the conventional treatment of cough after conventional pneumonia infection, the treatment group recieved the conventional budesonide aerosol inhalation therapy, and cough symptom scores were compared between the two groups before and 14 days after the treatment.Results There was no statistically significant difference before treatment between the two groups(P>0.05), and cough scores in the treatment group were significantly lower than those in the control group(P<0.05); The clinical efficacy of the treatment group was significantly higher than that of the control group(P<0.05). The hospitalization duration and cough disappearance time in the control group were significantly shorter than those in the control group(P<0.05).Conclusion Budesonide therapy applied on patients with cough following mycoplasma pneumonia infection can effectively improve cough symptom, shorten their hospitalization duraiton, and reduce the pain on patients. |
| Key words: Pneumonia infection Cough Budesonide Efficacy |
